[
  {
    "ts": null,
    "headline": "Does BMY's AI Collaboration With insitro Signal a New Growth Path in Neuroscience?",
    "summary": "On October 14, insitro and Bristol-Myers Squibb announced an extension of their collaboration to accelerate AI-driven discovery of novel small molecule therapies for amyotrophic lateral sclerosis (ALS), leveraging insitro’s ChemML™ platform and up to US$20 million in new funding for the next phase. If successful, the partnership could lead to milestone payments of over US$2 billion to insitro and further establish the role of advanced machine learning in tackling difficult neurological...",
    "url": "https://finnhub.io/api/news?id=bee99f5a0acce7167c77fd3480057113fc9e96f3f0bc61f05ffc4ae36aacf547",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760641978,
      "headline": "Does BMY's AI Collaboration With insitro Signal a New Growth Path in Neuroscience?",
      "id": 137122096,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "On October 14, insitro and Bristol-Myers Squibb announced an extension of their collaboration to accelerate AI-driven discovery of novel small molecule therapies for amyotrophic lateral sclerosis (ALS), leveraging insitro’s ChemML™ platform and up to US$20 million in new funding for the next phase. If successful, the partnership could lead to milestone payments of over US$2 billion to insitro and further establish the role of advanced machine learning in tackling difficult neurological...",
      "url": "https://finnhub.io/api/news?id=bee99f5a0acce7167c77fd3480057113fc9e96f3f0bc61f05ffc4ae36aacf547"
    }
  },
  {
    "ts": null,
    "headline": "HopeHealth Launches Phase 3 Clinical Trial Site To Advance Lupus Research With Support From Bristol Myers Squibb",
    "summary": "First HopeHealth Clinical Trial Marks Major Milestone for Access to Medical Research in Rural South Carolina Originally published on HopeHealth NORTHAMPTON, MA / ACCESS Newswire / October 16, 2025 / HopeHealth announced that it is participating in ...",
    "url": "https://finnhub.io/api/news?id=6cb841f2f949095ef8a39912d7678254edcffa1697d8c4bea7539da4ef2ee00f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760612400,
      "headline": "HopeHealth Launches Phase 3 Clinical Trial Site To Advance Lupus Research With Support From Bristol Myers Squibb",
      "id": 137104658,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "First HopeHealth Clinical Trial Marks Major Milestone for Access to Medical Research in Rural South Carolina Originally published on HopeHealth NORTHAMPTON, MA / ACCESS Newswire / October 16, 2025 / HopeHealth announced that it is participating in ...",
      "url": "https://finnhub.io/api/news?id=6cb841f2f949095ef8a39912d7678254edcffa1697d8c4bea7539da4ef2ee00f"
    }
  },
  {
    "ts": null,
    "headline": "NeoGenomics (NEO) Moves 6.3% Higher: Will This Strength Last?",
    "summary": "NeoGenomics (NEO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.",
    "url": "https://finnhub.io/api/news?id=eaf5d8353038468ff6839aa3157693d1a287e1e141c7a7a6bcf8650c9b18f44d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760601240,
      "headline": "NeoGenomics (NEO) Moves 6.3% Higher: Will This Strength Last?",
      "id": 137104659,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "NeoGenomics (NEO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.",
      "url": "https://finnhub.io/api/news?id=eaf5d8353038468ff6839aa3157693d1a287e1e141c7a7a6bcf8650c9b18f44d"
    }
  },
  {
    "ts": null,
    "headline": "insitro and Bristol Myers Squibb (BMY) Advance ALS Research with New AI-Powered Collaboration",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. On Oc​to⁠ber 14, insitro, a leader in applying ma​chi‌ne⁠ learnin‌g to drug d⁠iscovery a‍nd d⁠evel‍opme‍nt,⁠ and‍ Bristol-Myers Squibb Company (NYSE:BMY) annou⁠nced the ne⁠xt stag‍e of their partnership f‌ocuse‍d‌ on discovering ne​w‍ molecules for po⁠tenti‍al​ treatments of amyot⁠ro‌phic l‌ateral s⁠clerosis […]",
    "url": "https://finnhub.io/api/news?id=b7b625ca54c095b3501f62adbe2926fc88605e46a31bb0c28d67c84637f03f40",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760594965,
      "headline": "insitro and Bristol Myers Squibb (BMY) Advance ALS Research with New AI-Powered Collaboration",
      "id": 137102135,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. On Oc​to⁠ber 14, insitro, a leader in applying ma​chi‌ne⁠ learnin‌g to drug d⁠iscovery a‍nd d⁠evel‍opme‍nt,⁠ and‍ Bristol-Myers Squibb Company (NYSE:BMY) annou⁠nced the ne⁠xt stag‍e of their partnership f‌ocuse‍d‌ on discovering ne​w‍ molecules for po⁠tenti‍al​ treatments of amyot⁠ro‌phic l‌ateral s⁠clerosis […]",
      "url": "https://finnhub.io/api/news?id=b7b625ca54c095b3501f62adbe2926fc88605e46a31bb0c28d67c84637f03f40"
    }
  }
]